[1] Petri M.Systemic Lupus International Collaborating Clinic (SLICC):SLICC revision of the ACR classification criteria for SLE.Arthritis Rheum,2009,60(Suppl10):895. [2] 谢学光, 孙凌云.系统性红斑狼疮肝损害的临床分析.中华风湿病学杂志,2001,5:398. [3] Chowdhary VR, Crowson CS,Poterucha JJ, et al. Liver involvement in systemic lupus erythematosus: Case review of 40 patients. Rheumatol,2008,35:2159-2164. [4] 刘胜勇, 张冬平, 李学军. 抗平滑肌抗体、抗核抗体与慢性乙肝肝纤维化程度相关性研究. 中国现代医生, 2008. [5] Runyon BA, Labreque DR, Anuras S .The spectrum of liver disease in systemic lupus erythematosus: report of histologically proved cases and review of the literature.Am J Med, 1980, 69:187-194 . [6] Talenti DA , Falk GW , Carey WD , et al. Anticardiolipin antibody-associated cerebral infarction in cirrhosis: clearance of anticardiolipin antibody after liver transplantation. Am J Gastroenterol, 1994, 89:785-788. [7] Violi F, Ferro D, Quintarelli C, et al. Dilute APTT prolongation by antiphospholipid antibodies in patients with liver cirrhosis. Thromb Haemost,1990,63:183-186. [8] Violi F , Ferro D , Basili S , et al. Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver. BMJ, 1994, 309:239-240. [9] 俞幼林. 肝硬化脾功能亢进患者脾切除术后免疫功能变化.全科医学临床与教育,2010,8:400-401. |